| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
From the First Department of Medicine, Toyama Medical & Pharmaceutical University, Toyama, 930-0194 Japan
Address all correspondence and requests for reprints to: Toshiyasu Sasaoka, M.D., Ph.D., First Department of Medicine, Toyama Medical & Pharmaceutical University, 2630 Sugitani, Toyama, 930-0194, Japan. E-mail: tsasaoka-tym{at}umin.ac.jp
To examine the molecular mechanism of insulin receptor trafficking, we investigated the intracellular signaling molecules that regulate this process in Rat1 fibroblasts overexpressing insulin receptors. Cellular localization of insulin receptors was assessed by confocal laser microscopy with indirect immunofluorescence staining. Insulin receptors were visualized diffusely in the basal state. Insulin treatment induced the change of insulin receptor localization to perinuclear compartment. This insulin-induced insulin receptor trafficking was not affected by treatment of the cells with PI3-kinase inhibitor (wortmannin), whereas treatment with MEK [mitogen-activated protein (MAP) kinase-Erk kinase] inhibitor (PD98059) partly inhibited the process in a dose-dependent manner. Interestingly, treatment with both wortmannin and PD98059 almost completely inhibited insulin receptor trafficking. The functional importance of PI3-kinase and MAP kinase in the trafficking process was directly assessed by using single cell microinjection analysis. Microinjection of p85-SH2 and/or catalytically inactive MAP kinase ([K71A]Erk1) GST fusion protein gave the same results as treatment with wortmannin and PD98059. Furthermore, to determine the crucial step for the requirement of PI3-kinase and MAP kinase pathways, the effect of wortmannin and PD98059 on insulin receptor endocytosis was studied. Insulin internalization from the plasma membrane and subsequent insulin degradation were not affected by treatment with wortmannin and PD98059. In contrast, insulin receptor down-regulation from the cell surface and insulin receptor degradation, after prolonged incubation with insulin, were markedly impaired by the treatment. These results suggest that PI3-kinase and MAP kinase pathways synergistically regulate insulin receptor trafficking at a step subsequent to the receptor internalization.
This article has been cited by other articles:
![]() |
S. Boura-Halfon, H. Voliovitch, R. Feinstein, K. Paz, and Y. Zick Extracellular Matrix Proteins Modulate Endocytosis of the Insulin Receptor J. Biol. Chem., April 25, 2003; 278(18): 16397 - 16404. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. He, D. D. Browning, and R. D. Ye Differential Roles of the NPXXY Motif in Formyl Peptide Receptor Signaling J. Immunol., March 15, 2001; 166(6): 4099 - 4105. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Carrillo, B. Ibares, A. Esteban-Gamboa, and J. E. Feliu Involvement of Both Phosphatidylinositol 3-Kinase and p44/p42 Mitogen-Activated Protein Kinase Pathways in the Short-Term Regulation of Pyruvate Kinase L by Insulin Endocrinology, March 1, 2001; 142(3): 1057 - 1064. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. W. Kang, J. H. Ryu, and S. G. Kim The Essential Role of Phosphatidylinositol 3-Kinase and of p38 Mitogen-Activated Protein Kinase Activation in the Antioxidant Response Element-Mediated rGSTA2 Induction by Decreased Glutathione in H4IIE Hepatoma Cells Mol. Pharmacol., November 1, 2000; 58(5): 1017 - 1025. [Abstract] [Full Text] |
||||
![]() |
F. Blanchard, L. Duplomb, Y. Wang, O. Robledo, E. Kinzie, V. Pitard, A. Godard, Y. Jacques, and H. Baumann Stimulation of Leukemia Inhibitory Factor Receptor Degradation by Extracellular Signal-regulated Kinase J. Biol. Chem., September 8, 2000; 275(37): 28793 - 28801. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-j. Liu, H.-c. Lai, W. Wu, S. Chinn, and P. H. Wang Developing a Strategy to Define the Effects of Insulin-Like Growth Factor-1 on Gene Expression Profile in Cardiomyocytes Circ. Res., June 22, 2001; 88(12): 1231 - 1238. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |